172 related articles for article (PubMed ID: 36104215)
41. PTEN/AKT/mTOR signaling mediates anticancer effects of epigallocatechin‑3‑gallate in ovarian cancer.
Qin J; Fu M; Wang J; Huang F; Liu H; Huangfu M; Yu D; Liu H; Li X; Guan X; Chen X
Oncol Rep; 2020 Jun; 43(6):1885-1896. PubMed ID: 32236585
[TBL] [Abstract][Full Text] [Related]
42. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
[TBL] [Abstract][Full Text] [Related]
43. Gamma irradiation of ocular melanoma and lymphoma cells in the presence of gold nanoparticles: in vitro study.
Kanavi MR; Asadi S; Balagholi S; Alikarami F; Nosrati H; Ahmadieh H
J Appl Clin Med Phys; 2018 May; 19(3):268-275. PubMed ID: 29707895
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of microwave hyperthermia and chemotherapy in the presence of gold nanoparticles: an in vitro study on osteosarcoma.
Ghahremani FH; Sazgarnia A; Bahreyni-Toosi MH; Rajabi O; Aledavood A
Int J Hyperthermia; 2011; 27(6):625-36. PubMed ID: 21846198
[TBL] [Abstract][Full Text] [Related]
45. A novel PI3K/mTOR dual inhibitor, CMG002, overcomes the chemoresistance in ovarian cancer.
Choi HJ; Heo JH; Park JY; Jeong JY; Cho HJ; Park KS; Kim SH; Moon YW; Kim JS; An HJ
Gynecol Oncol; 2019 Apr; 153(1):135-148. PubMed ID: 30686552
[TBL] [Abstract][Full Text] [Related]
46. Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses.
Kang S; Ahn S; Lee J; Kim JY; Choi M; Gujrati V; Kim H; Kim J; Shin EC; Jon S
J Control Release; 2017 Jun; 256():56-67. PubMed ID: 28428066
[TBL] [Abstract][Full Text] [Related]
47. Overendocytosis of gold nanoparticles increases autophagy and apoptosis in hypoxic human renal proximal tubular cells.
Ding F; Li Y; Liu J; Liu L; Yu W; Wang Z; Ni H; Liu B; Chen P
Int J Nanomedicine; 2014; 9():4317-30. PubMed ID: 25246788
[TBL] [Abstract][Full Text] [Related]
48. Amoxicillin functionalized gold nanoparticles reverts MRSA resistance.
Kalita S; Kandimalla R; Sharma KK; Kataki AC; Deka M; Kotoky J
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():720-7. PubMed ID: 26838902
[TBL] [Abstract][Full Text] [Related]
49. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.
Bi X; Lv X; Liu D; Guo H; Yao G; Wang L; Liang X; Yang Y
Cancer Gene Ther; 2021 Apr; 28(3-4):335-349. PubMed ID: 32939058
[TBL] [Abstract][Full Text] [Related]
50. Establishment of a trimodality analytical platform for tracing, imaging and quantification of gold nanoparticles in animals by radiotracer techniques.
Chen CH; Lin FS; Liao WN; Liang SL; Chen MH; Chen YW; Lin WY; Hsu MH; Wang MY; Peir JJ; Chou FI; Chen CY; Chen SY; Huang SC; Yang MH; Hueng DY; Hwu Y; Yang CS; Chen JK
Anal Chem; 2015 Jan; 87(1):601-8. PubMed ID: 25424326
[TBL] [Abstract][Full Text] [Related]
51. Exploring the cell uptake mechanism of phospholipid and polyethylene glycol coated gold nanoparticles.
Hao Y; Yang X; Song S; Huang M; He C; Cui M; Chen J
Nanotechnology; 2012 Feb; 23(4):045103. PubMed ID: 22222168
[TBL] [Abstract][Full Text] [Related]
52. Gold nanoparticle amplification strategies for multiplex SPRi-based immunosensing of human pancreatic islet hormones.
Castiello FR; Tabrizian M
Analyst; 2019 Apr; 144(8):2541-2549. PubMed ID: 30864587
[TBL] [Abstract][Full Text] [Related]
53. Enhanced radiation sensitivity in prostate cancer by gold-nanoparticles.
Zhang X; Xing JZ; Chen J; Ko L; Amanie J; Gulavita S; Pervez N; Yee D; Moore R; Roa W
Clin Invest Med; 2008; 31(3):E160-7. PubMed ID: 18544279
[TBL] [Abstract][Full Text] [Related]
54. Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy.
Chen Y; Yang J; Fu S; Wu J
Int J Nanomedicine; 2020; 15():9407-9430. PubMed ID: 33262595
[TBL] [Abstract][Full Text] [Related]
55. Targeted dose enhancement in radiotherapy for breast cancer using gold nanoparticles, part 1: A radiobiological model study.
Ferrero V; Visonà G; Dalmasso F; Gobbato A; Cerello P; Strigari L; Visentin S; Attili A
Med Phys; 2017 May; 44(5):1983-1992. PubMed ID: 28236655
[TBL] [Abstract][Full Text] [Related]
56. Liver uptake of gold nanoparticles after intraperitoneal administration in vivo: a fluorescence study.
Abdelhalim MA; Mady MM
Lipids Health Dis; 2011 Oct; 10():195. PubMed ID: 22040092
[TBL] [Abstract][Full Text] [Related]
57. Chemical Radiosensitivity of DNA Induced by Gold Nanoparticles.
Yao X; Huang C; Chen X; Yi Z; Sanche L
J Biomed Nanotechnol; 2015 Mar; 11(3):478-85. PubMed ID: 26307830
[TBL] [Abstract][Full Text] [Related]
58. Nanoparticle-protein interactions: a thermodynamic and kinetic study of the adsorption of bovine serum albumin to gold nanoparticle surfaces.
Boulos SP; Davis TA; Yang JA; Lohse SE; Alkilany AM; Holland LA; Murphy CJ
Langmuir; 2013 Dec; 29(48):14984-96. PubMed ID: 24215427
[TBL] [Abstract][Full Text] [Related]
59. Surface chemistry governs the sub-organ transfer, clearance and toxicity of functional gold nanoparticles in the liver and kidney.
Li X; Wang B; Zhou S; Chen W; Chen H; Liang S; Zheng L; Yu H; Chu R; Wang M; Chai Z; Feng W
J Nanobiotechnology; 2020 Mar; 18(1):45. PubMed ID: 32169073
[TBL] [Abstract][Full Text] [Related]
60. Gold nanoparticles regulate the blimp1/pax5 pathway and enhance antibody secretion in B-cells.
Lee CH; Syu SH; Chen YS; Hussain SM; Aleksandrovich Onischuk A; Chen WL; Steven Huang G
Nanotechnology; 2014 Mar; 25(12):125103. PubMed ID: 24576992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
